Nat Rev Cancer. 2006 Jan;6(1):38-51.

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.

Source

Department of Experimental Oncology, European Institute of Oncology, Via Ripamanti 435, 20141, Milan, Italy. saverio.minucci@ifom-ieo-campus.it

Abstract

Histone deacetylases (HDACs) are considered to be among the most promising targets in drug development for cancer therapy, and first-generation histone deacetylase inhibitors (HDACi) are currently being tested in phase I/II clinical trials. A wide-ranging knowledge of the role of HDACs in tumorigenesis, and of the action of HDACi, has been achieved. However, several basic aspects are not yet fully understood. Investigating these aspects in the context of what we now understand about HDACi action both in vitro and in vivo will further improve the design of optimized clinical protocols.

PMID:: 16397526; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Cancer - MedlinePlus Health Information

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Review Cytotoxicity mediated by histone deacetylase inhibitors in cancer cells: mechanisms and potential clinical implications. [Clin Cancer Res. 2009]
Review Cytotoxicity mediated by histone deacetylase inhibitors in cancer cells: mechanisms and potential clinical implications.
Schrump DS. Clin Cancer Res. 2009 Jun 15; 15(12):3947-57. Epub 2009 Jun 9.
Review HDACi--going through the mechanisms. [Front Biosci. 2011]
Review HDACi--going through the mechanisms.
Wanczyk M, Roszczenko K, Marcinkiewicz K, Bojarczuk K, Kowara M, Winiarska M. Front Biosci. 2011 Jan 1; 16:340-59. Epub 2011 Jan 1.
Review Recent advances in histone deacetylase targeted cancer therapy. [Surg Today. 2010]
Review Recent advances in histone deacetylase targeted cancer therapy.
Hoshino I, Matsubara H. Surg Today. 2010 Sep; 40(9):809-15. Epub 2010 Aug 26.
Review Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancer. [Cancer Lett. 2009]
Review Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancer.
Botrugno OA, Santoro F, Minucci S. Cancer Lett. 2009 Aug 8; 280(2):134-44. Epub 2009 Apr 2.
Review Focus on acetylation: the role of histone deacetylase inhibitors in cancer therapy and beyond. [Expert Opin Investig Drugs. 2007]
Review Focus on acetylation: the role of histone deacetylase inhibitors in cancer therapy and beyond.
Konstantinopoulos PA, Karamouzis MV, Papavassiliou AG. Expert Opin Investig Drugs. 2007 May; 16(5):569-71.

See reviews... See all...

Cited by over 100 PubMed Central articles

Analysis of the Hox epigenetic code. [World J Clin Oncol. 2012]
Analysis of the Hox epigenetic code.
Ezziane Z. World J Clin Oncol. 2012 Apr 10; 3(4):48-56.
Histone deacetylase inhibitors in cell pluripotency, differentiation, and reprogramming. [Stem Cells Int. 2012]
Histone deacetylase inhibitors in cell pluripotency, differentiation, and reprogramming.
Kretsovali A, Hadjimichael C, Charmpilas N. Stem Cells Int. 2012; 2012:184154. Epub 2012 Mar 8.
Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation. [Proc Natl Acad Sci U S A. 2012]
Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation.
Lee H, Zhang P, Herrmann A, Yang C, Xin H, Wang Z, Hoon DS, Forman SJ, Jove R, Riggs AD, et al. Proc Natl Acad Sci U S A. 2012 May 15; 109(20):7765-9. Epub 2012 Apr 30.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatmen...
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.
Nat Rev Cancer. 2006 Jan ;6(1):38-51.

PubMed
Long-term comprehensive care of cardiac patients. Recommendations by the Working...
Long-term comprehensive care of cardiac patients. Recommendations by the Working Group on Rehabilitation of the European Society of Cardiology.
Eur Heart J. 1992 Jul ;13 Suppl C:1-45.

PubMed
Molecular analysis of human and bovine tubercle bacilli from a local setting in ...
Molecular analysis of human and bovine tubercle bacilli from a local setting in Nigeria.
J Clin Microbiol. 2006 Jan ;44(1):29-34.

PubMed
Acceleration of onset of collagen-induced arthritis by intra-articular injection...
Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta.
Clin Exp Immunol. 1992 Aug ;89(2):244-50.

PubMed
Doublecortin-like kinase functions with doublecortin to mediate fiber tract decu...
Doublecortin-like kinase functions with doublecortin to mediate fiber tract decussation and neuronal migration.
Neuron. 2006 Jan 5 ;49(1):55-66.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: